Drugs already licensed could be trialled to potentially treat secondary brain cancer
The largest review of papers for brain cancer that has spread from the lungs has…
The largest review of papers for brain cancer that has spread from the lungs has…
For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status,…
November is Lung Cancer Awareness Month and as the fourth most diagnosed cancer and the…
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival…
The results from the Phase 3 MARIPOSA study were announced showing amivantamab-vmjw in combination with…
The results from the Phase 3 MARIPOSA-2 study have been announced showing the regimen of…
More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs…
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery…
In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan…
On October 11, 2023, the Food and Drug Administration approved encorafenib with binimetinib for adult patients with…